[ad_1] Moderna in Cambridge, MA is pictured on Feb. 28, 2020. David L. Ryan | The Boston Globe via Getty Images A member of Moderna’s board of directors resigned to avoid any “potential or even apparent conflict of interest” during the company’s phase three trial for its potential coronavirus vaccine,Continue Reading

[ad_1] Albert Bourla, Pfizer Gian Ehrenzeller | Keystone | AP President Donald Trump’s executive orders aimed at lowering U.S. prescription drug costs will cause “enormous destruction” as the pharmaceutical industry races to develop vaccines and treatments for the coronavirus, Pfizer CEO Albert Bourla told investors Tuesday. Trump on Friday signed four executive ordersContinue Reading